跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rhamnetin
首页
药物
Rhamnetin
Experimental
Small Molecule
Rhamnetin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
16
H
12
O
7
CAS 编号
90-19-7
UNII ID
71803L5F4S
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutical application of rhamnetin
申请人: SHANGHAI YIZHI MEDICINE TECHNOLOGY CO LTD
优先权: 2017
CN
Device for extracting black rhamnetin from pitaya branches
申请人: GUANGXI GUIRUN TRADE CO LTD
优先权: 2022
CN
Pharmaceutical application of rhamnetin-3-O-alpha-rhamnoside and anti-inflammatory drug
申请人: UNIV SHANXI MEDICAL
优先权: 2021
CN
Fusion protein containing flavone methyltransferase, preparation method and application of fusion protein in efficient synthesis of rhamnetin
申请人: UNIV JIANGNAN
优先权: 2024
CN
NOVEL COMPOUND DERIVED FROM LORANTHUS TANAKAE AND ANTICANCER USE THEREOF
申请人: KOREA INST ORIENTAL MEDICINE
优先权: 2022
US
WO
2 件公开
THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS
申请人: LOWE HENRY
优先权: 2015
US
3 件公开
METHODS FOR TREATING CORONAVIRUS INFECTION
申请人: RABINOFF MICHAEL
优先权: 2022
US
NATURALLY AVAILABLE FRUIT-DERIVED COMPOUNDS TESTED TO DOCK WITH PRESENILIN-1 AND AMYLOID PRECURSOR PROTEIN
申请人: DASGUPTA SUBHAJIT
优先权: 2023
US
药物
反馈